Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA plus ezetimibe crossover study in hypercholesterolemia
NL-OMON47926Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ursodeoxycholic acid and ezetimibe in hypercholesterolemia (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Total fecal sterol concentration. Started Apr 2018; status: active, not recruiting.
02
Drugs
ursodeoxycholic acidezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NL-OMON47926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47926.